EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients With Infective Endocarditis: A Target Trial Emulation

Teddy Tai Loy Lee iD, Chengsheng Ju iD, Sunny Ching Long Chan iD, Oscar Hou In Chou, Jeffrey Shi Kai Chan iD, Sharen Lee iD, Tong Liu iD, Shuk Han Cheng iD, Yuhui Zhang iD, Bernard Man Yung Cheung iD, Abraham Ka-Chung Wai iD, Li Wei iD und 1 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.125.041965 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Teddy Tai Loy Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, School of Clinical Medicine The University of Hong Kong Hong Kong China. Hauptthemen laut MEDLINE: Warfarin, Heart Failure, Anticoagulants, Endocarditis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infective endocarditis (IE) can be complicated by acute heart failure and bacteremia, which can account for increased mortality. The role of anticoagulation with warfarin in IE is controversial. This study aimed to study the effects of anticoagulation with warfarin on survival in patients with IE, through reducing the risks of thromboembolism and possibly shortening infection time.

Methods

This was a retrospective population‐based cohort study using the Clinical Data Analysis and Reporting System from Hong Kong. Patients diagnosed with IE between January 1, 1997 and August 31, 2020 were identified using International Classification of Diseases, Ninth Revision ( ICD‐9 ) codes. A target pragmatic trial was emulated using the observational data with cloning‐censoring‐weighting approach, comparing the treatment effect of initiation warfarin within 14 days versus no warfarin on the risk of all‐cause mortality, acute heart failure, and achieving negative blood culture in patients with IE. Pooled logistic regression was applied to estimate 12‐week survival or cumulative incidence differences and risk ratios (RRs).

Results

A total of 5121 patients with IE with an average age of 55.7 years (SD:18.9) were included. Warfarin use was associated with lower risks of all‐cause mortality with 12‐week survival difference of 6.5% (95% CI, 2.6%–9.9%) and RR of 0.72 (95% CI, 0.57–0.88) and a greater benefit of achieving negative blood cultures with 12‐week cumulative incidence difference of 11.4% (95% CI, 5.4%–16.5%) and RR of 1.13 (95% CI, 1.06–1.20) but similar risks of acute heart failure (RR, 1.07 [95% CI, 0.87–1.30]).

Conclusions

Patients with IE initiating warfarin had significantly lower risk of mortality with potential benefits on achieving negative blood cultures, suggesting benefit in infection resolution but a similar risk of acute heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WarfarinHeart FailureAnticoagulantsEndocarditisHumansMaleFemaleMiddle AgedRetrospective StudiesHong KongAgedRisk AssessmentAcute DiseaseRisk FactorsAdult

Stichwörter der Autor:innen

anticoagulationcausal inferenceinfective endocarditistrial emulation

Substanzen

WarfarinAnticoagulants

Autor:innen und Institutionen

  • Department of Emergency Medicine, School of Clinical Medicine The University of Hong Kong Hong Kong China.
  • Cardiovascular Pharmacology Unit, Cardiovascular Analytics Group PowerHealth Research Institute Hong Kong China.
  • Research Department of Practice and Policy, School of Pharmacy University College London London United Kingdom.
  • Institute of Cardiovascular Science, University College London London United Kingdom.
  • Division of Clinical Pharmacology, School of Clinical Medicine The University of Hong Kong Hong Kong China.
  • Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University Tianjin China.

ORCID-Profile: Teddy Tai Loy Lee, Chengsheng Ju, Sunny Ching Long Chan, Jeffrey Shi Kai Chan, Sharen Lee, Tong Liu, Shuk Han Cheng, Yuhui Zhang, Bernard Man Yung Cheung, Abraham Ka-Chung Wai, Li Wei, Gary Tse

Zitieren

APA

Lee, T. T. L., Ju, C., Chan, S. C. L., Chou, O. H. I., Chan, J. S. K., Lee, S., Liu, T., Cheng, S. H., Zhang, Y., Cheung, B. M. Y., Wai, A. K., Wei, L., & Tse, G. (2025). Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients With Infective Endocarditis: A Target Trial Emulation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.041965

Vancouver

Lee TTL, Ju C, Chan SCL, Chou OHI, Chan JSK, Lee S, et al. Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients With Infective Endocarditis: A Target Trial Emulation. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.041965

BibTeX
@article{Lee2025,
  author = {Lee, Teddy Tai Loy and Ju, Chengsheng and Chan, Sunny Ching Long and Chou, Oscar Hou In and Chan, Jeffrey Shi Kai and Lee, Sharen and Liu, Tong and Cheng, Shuk Han and Zhang, Yuhui and Cheung, Bernard Man Yung and Wai, Abraham Ka-Chung and Wei, Li and Tse, Gary},
  title = {Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients With Infective Endocarditis: A Target Trial Emulation},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.125.041965}
}
Kostenlos starten →